Search Results 651-660 of 19708 for Receptor
He also leads industry-funded clinical trials of vasopressin V2 receptor antagonists, which have led to the development of the first internationally ...
Outcomes of Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE in Patients with Metastatic Pheochromocytoma and Paraganglioma. J Nucl Med. 2026 Jan ...
Efgartigimod alfa-fcab injection is used to treat a nerve and muscle problem called myasthenia gravis in patients who are anti-acetylcholine receptor (AChR) ...
... receptor (EGFR) gene (exon 19 deletions or exon 21 L858R substitution mutations). Your doctor will perform a test before you take this medicine. This ...
Estrogen receptor positive breast cancer; Fibroadenoma · Galactorrhea; Genetic predisposition to breast cancer; HER2-positive breast cancer; High risk for ...
... receptor antagonist in adults with a clinical diagnosis of rheumatoid arthritis. Participation eligibility. Participant eligibility includes age, gender ...
The discussion will center on Mayo's groundbreaking work in 3D bioprinting, genetic engineering and expanding chimeric antigen receptor therapy (CAR-T cell ...
Ranolazine is used to treat chronic angina (chest pain). This medicine is usually used together with other medicines (eg, ACE inhibitors, angiotensin receptor ...
... receptor (CAR) T-cell therapy. Brentuximab interferes with the growth of cancer cells, which are then destroyed by the body. This medicine is to be given ...
Scottsdale/Phoenix, Ariz. The purpose of this study is tol compare the effect of retreatment with 177Lu-DOTATATE peptide receptor radionuclide therapy ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.